SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:DiVA.org:umu-25669"
 

Search: id:"swepub:oai:DiVA.org:umu-25669" > Vandetanib alters t...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00002971naa a2200325 4500
001oai:DiVA.org:umu-25669
003SwePub
008090827s2010 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-256692 URI
024a https://doi.org/10.3892/ijo_000007392 DOI
040 a (SwePub)umu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Wibom, Carl,d 1977-u Umeå universitet,Onkologi4 aut0 (Swepub:umu)caewim02
2451 0a Vandetanib alters the protein pattern in malignant glioma and normal brain in the BT4C rat glioma model
264 1b Spandidos Publications,c 2010
338 a print2 rdacarrier
520 a The treatment of glioblastoma is unsatisfactory. Improved understanding of the biological effects of treatment, together with development of new tools to predict outcome of the initiated treatment are therefore of great need. Vandetanib (ZD6474) is mainly a vascular endothelial growth factor (VEGF) and epidermal growth factor (EGF) receptor tyrosine kinase inhibitor. This study investigated the pattern of protein expression in brain tumor and normal brain tissue, following treatment with vandetanib in a rat glioma model. BT4C-cells were stereotactically implanted into the brain of BD IX rats. The rats were divided into three different experiments. The treatment schedule for experiments one and two consisted of daily, oral doses of vandetanib from day 6 until day 12 or 20 after implantation, respectively. In the third experiment, each animal received a single dose of vandetanib on day 19 after implantation and was then sacrificed 2, 8 or 24 h thereafter. The protein expression profiles were analyzed by SELDI-TOF-MS and evaluated with multivariate statistical methods. Following treatment with vandetanib, we found significantly altered protein expression pattern in malignant glioma and normal brain. Analyzing protein spectra is an interesting option to assess biological effects induced in brain tissue by signal transduction inhibitors such as vandetanib.
700a Sandström, Mariau Umeå universitet,Onkologi4 aut0 (Swepub:umu)maalin96
700a Henriksson, Rogeru Umeå universitet,Onkologi4 aut0 (Swepub:umu)rohe0003
700a Antti, Henriku Umeå universitet,Kemiska institutionen4 aut0 (Swepub:umu)hean0004
700a Johansson, Mikaelu Umeå universitet,Onkologi4 aut0 (Swepub:umu)mijo0025
700a Bergenheim, A Tommyu Umeå universitet,Neurokirurgi4 aut0 (Swepub:umu)tobe0004
710a Umeå universitetb Onkologi4 org
773t International Journal of Cancerd : Spandidos Publicationsg 37:4, s. 879-890q 37:4<879-890x 0020-7136x 1097-0215x 1019-6439x 1791-2423
856u https://www.spandidos-publications.com/ijo/37/4/879/download
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-25669
8564 8u https://doi.org/10.3892/ijo_00000739

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view